Rfp Financial Group LLC Moderna, Inc. Transaction History

Rfp Financial Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$101.21 - $166.61 $303 - $499	3 Added 4.84%	65 $7,000
Q1 2024 May 09, 2024	SELL	$85.37 - $115.44 $3,329 - $4,502	-39 Reduced 38.61%	62 $6,000
Q4 2023 Feb 12, 2024	BUY	$69.51 - $104.43 $2,988 - $4,490	43 Added 74.14%	101 $10,000
Q1 2023 Apr 26, 2023	SELL	$135.66 - $197.02 $6,783 - $9,851	-50 Reduced 46.3%	58 $8.91 Million
Q4 2022 Jan 24, 2023	BUY	$118.38 - $210.04 $12,785 - $22,684	108 New	108 $19.4 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Rfp Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Rfp Financial Group LLC with notifications on news.